Abstract
When treating patients with bladder cancer their division into muscle infiltrating and non-infiltrating tumors is important,because the prognosis and therapy in these two groups differ substantially. The basic treatment of non-infiltrating tumors is transurethral resection.
For successful treatment after transurethral resection is important to determine prognostic factors.This allows us to classify patients into individual risk groups. Based on extensive meta-analyzes a different treatment and follow-up method is recommended for each risk group.
The basis of muscle-infiltrating tumors therapy is radical cystectomy followed by urinary derivation. Overall survival of these patients may be improved by neoadjuvant chemotherapy.